We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe Axsome to receive an upfront payment of $66...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.35 | 3.35 | 3.35 | 666 | 3.35 | DE |
4 | 0 | 0 | 3.35 | 3.35 | 3.35 | 1295 | 3.35 | DE |
12 | 0 | 0 | 3.35 | 3.35 | 3.35 | 1380 | 3.35 | DE |
26 | 0 | 0 | 3.35 | 3.35 | 3.35 | 822 | 3.35 | DE |
52 | 0 | 0 | 3.35 | 3.35 | 3.35 | 603 | 3.35 | DE |
156 | 0 | 0 | 3.35 | 3.35 | 3.35 | 638 | 3.35 | DE |
260 | 0 | 0 | 3.35 | 3.35 | 3.35 | 638 | 3.35 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions